COMP <GO>
IMAX vs MA // 10Y YIELD & FRED MACRO BETA
Imax Corporation (NYSE) VS. Mastercard Incorporated (NYSE) • 15-METRIC TALLY: IMAX 3
— MA 8
■ METRIC PARITY
LAST: $51.34 (+1.62%) • MKT CAP: $2.82B
macro-sensitivity
—
LAST: $635.70 (+4.16%) • MKT CAP: $556.88B
macro-sensitivity
0.90
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMAX VS. MA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMAX | MA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 60.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 35.60% | 33.50% | +2.10 | IMAX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.2x | 29.2x | 0.00 | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.22% | 3.08% | +1.14 | IMAX | /fcf-yield <GO> |
| Operating Margin | 20.50% | 57.60% | -37.10 | MA | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 45.60% | -37.10 | MA | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | 16.40% | +0.10 | IMAX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | MA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.02 | 11.17 | -7.15 | MA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | MA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.5 | 68.8 | -25.25 | MA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.90 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 67.8x | 31.2x | +36.60 | MA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.82B | $556.88B | -$554.06B | MA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMAX REV | MA REV | IMAX GROSS % | MA GROSS % | IMAX FCF | MA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $410.2M | $32.79B | 60.0% | — | $118.9M | $17.16B |
| FY 2024 | $352.2M | $28.17B | 54.0% | — | $62.4M | $14.31B |
| FY 2023 | $374.8M | $25.10B | — | — | $58.6M | $10.85B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMAX // BETA —
MA // BETA 0.90